Innoviva is trading at $22.71, up 6.47% in pre-market; the catalyst remains unclear.
- No company-specific announcement, earnings release, filing, or analyst action dated September 8, 2026, was identified; the latest listed release was September 2.
- Broader markets were mixed: the Nasdaq rose 0.26%, while the S&P 500 and Dow fell, so macro sentiment does not clearly explain the move.